Overview of Substance Use Disorder

Target Audience

This activity is intended for practitioners with a DEA registration to prescribe controlled substances (ie. any clinician with prescriptive authority - MD, DO, APRN, PA, CRNA, etc).

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Define the full spectrum of substance use.
  2. Describe the epidemiology of substance use disorder (SUD).
  3. Review screening and diagnosis for SUD.
  4. Delineate components of effective treatment.

Additional Information

Provided by: 

Course summary
Available credit: 
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
05/17/2023
Course expires: 
05/17/2024
Cost:
$0.00
Part of: 
Substance Use Disorder Basics (for BORIM)

Sarah E. Wakeman, MD
Medical Director for Substance Use Disorder, Office of the Chief Medical Officer, Mass General Brigham
Associate Professor of Medicine, Harvard Medical School

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 CreditTM
Mass General Brigham designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Disclosure Summary of Relevant Financial Relationships

The following planners have reported no relevant financial relationship with an ineligible company:
Robert Birnbaum, MD, PhD
Sarah Wakeman, MD

The following speakers have reported no relevant financial relationships an ineligible company:
Sarah Wakeman, MD

Available Credit

  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.